Yahoo Web Search

  1. Web results

  2. Organon Pharmaceuticals USA, Inc.: Private Company ...

    Organon Pharmaceuticals USA, Inc. engages in developing and producing prescription medicines for gynecology, psychiatry, cardiovascular disease, immunology, and anesthesia. The company is based in ...

  3. US Business Directory. State: New Jersey. Businesses starting with OR. Page 232.

  4. | Homepage

    This website of Merck & Co., Inc., Kenilworth, NJ, USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995.

  5. Organon Pharmaceuticals Usa Inc - Manta

    Organon Pharmaceuticals Usa Inc is a privately held company in Roseland, NJ and is a Headquarters business. Categorized under Pharmaceutical Preparations. Our records show it was established in 1937 and incorporated in New Jersey.

  6. Organon Pharmaceuticals USA Inc. - Dun & Bradstreet

    Find the Organon Pharmaceuticals USA Inc. business page in Roseland, NJ. Explore the NJ Credibility Review business directory at

  7. Organon International - Wikipedia

    Organon was a pharmaceutical company headquartered in Oss, Netherlands.In November 2007, Schering-Plough Corporation, based in New Jersey, USA, acquired Organon, active pharmaceutical ingredient producer Diosynth (separate from Organon until 2004), and its veterinary pharmaceutical sister company Intervet from Akzo Nobel.

  8. Organon Pharmaceuticals USA Inc. Names James ... - BioSpace

    ROSELAND, N.J., March 21 /PRNewswire/ -- Organon Pharmaceuticals USA Inc. has named James G. Harmon Vice President, Managed Markets. Harmon has an impressive breadth of experience in the areas of managed markets and sales that spans over 20 years in the pharmaceutical industry.

  9. Scrip

    Government contends a price reduction is the only discount exception to the Anti-Kickback Statute; PhRMA says this interpretation puts companies at risk of criminal liability for other discount arrangements.


    Organon USA Inc., 883 F. Supp. 2d 277, 283–85 (D. Mass. 2012), leaving only a brief recitation necessary here. Relators allege that Omnicare both solicited and received kickbacks from

  11. Page 4: Organon Pharmaceuticals USA: TICE BCG is indicated for the treatment and prophylaxis of carcinoma in situ (CIS) of the urinary bladder, and for the...

  1. Ad
    related to Organon Pharmaceuticals USA, Inc